Adam Salmon, PhD, an Assistant Professor of Research in the Department of Molecular Medicine and the Barshop Institute, has received a $2.7 million R01 award from the NIH National Institute on Aging to study the role of mTOR inhibition in longevity and aging in a non-human primate.
Read MoreRapamycin and Alzheimer’s disease: Time for a clinical trial? Kaeberlein M, Galvan V Sci Transl Med. 2019 Jan 23;11(476).
read moreLong-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets. Sills AM,
read moreSara Espinoza, MD, MSc, an Associate Professor in the Department of Medicine and the Barshop Institute, has received a
read moreAdam Salmon, PhD, an Assistant Professor of Research in the Department of Molecular Medicine and the Barshop Institute, has
read more
